-
Mashup Score: 4Enfortumab Vedotin approved in EU for urothelial cancer - 2 year(s) ago
The approval was based on data from the phase 3 EV-301 trial, in which enfortumab vedotin reduced the risk of death by 30% versus chemotherapy in patients with heavily pretreated locally advanced or metastatic urothelial carcinoma.
Source: Urology TimesCategories: Latest Headlines, UrologyTweet
-
Mashup Score: 0Study shows value of radical cystectomy–pentafecta for measuring quality of RARC surgery - 2 year(s) ago
Patients achieving RC-pentafecta had less blood loss, shorter hospital stays, and lower perioperative mortality.
Source: Urology TimesCategories: Latest Headlines, UrologyTweet-
New metric effectively measures quality of RARC surgery for high-risk bladder cancer https://t.co/5fBFrNsCBG #urology #urologist #cystectomy #urooncology #bladder
-
-
Mashup Score: 0Dr. J. Stephen Jones highlights the emergence and evolution of cryotherapy in urology - 2 year(s) ago
“Throughout the years, I’ve said it’s not hard to destroy tissue; it’s hard to destroy tissue without destroying other things around [the cancer],” says J. Stephen Jones, MD, FACS.
Source: Urology TimesCategories: Latest Headlines, UrologyTweet-
Dr. J. Stephen Jones reflects on the the emergence and evolution of cryotherapy in urology https://t.co/ckO9HOydwM #urology #urologist #kidney #urooncology #prostatecancer #prostate
-
-
Mashup Score: 0
“Cryotherapy was the first energy source that we were able to ablate tissues with in either the kidney or prostate and understand what that ablation would do,” says J. Stephen Jones, MD, FACS.
Source: Urology TimesCategories: Latest Headlines, UrologyTweet-
Dr. J. Stephen Jones, MD, FACS, discusses cryotherapy for kidney and prostate cancer https://t.co/bIMQoQ2LaK #urology #urologist #cryotherapy #prostatecancer #kcsm #urooncology
-
-
Mashup Score: 0
The approval was based on results from the randomized, double-blind phase 3 CheckMate-274 trial.
Source: Urology TimesCategories: Latest Headlines, UrologyTweet-
Nivolumab approved in EU for adjuvant treatment of muscle-invasive urothelial carcinoma https://t.co/TV65NIdFWA #urology #urologist #bladdercancer #urooncology
-
-
Mashup Score: 0Dr. Lee on factors that led to an increase in same-day discharge after robotic surgery - 2 year(s) ago
“We would have monthly multidisciplinary meetings to pick each other’s brains for tips we can use to get patients home more safely and quickly after surgery,” says Lee.
Source: Urology TimesCategories: Latest Headlines, UrologyTweet-
Dr. David Lee discusses how multidisciplinary collaboration and the circumstances of the pandemic led to an increase in same-day discharge after robotic surgery cancer https://t.co/IZY74Xi3VG #urology #urologist #urooncology
-
-
Mashup Score: 0The Multidisciplinary Approach to Prostate Cancer Management - 2 year(s) ago
An explanation of the importance of clinical providers following a multidisciplinary approach for prostate cancer management.
Source: Urology TimesCategories: Latest Headlines, UrologyTweet-
Video: Experts highlight the importance of clinical providers following a multidisciplinary approach for prostate cancer management. https://t.co/HBBrTeAFCA #urology #urologist #prostate #urooncology
-
-
Mashup Score: 0
Eligible patients for the multicenter, nonrandomized, single-arm trial (NCT05249127) will have suspected recurrence of prostate cancer as determined by a rising prostate-specific antigen following definitive therapy.
Source: Urology TimesCategories: Latest Headlines, UrologyTweet-
Enrollment opens for study of Cu-64 SAR-bisPSMA in biochemically recurrent prostate cancer https://t.co/oDixZM8x4v #urology #urologist #prostatecancer #urooncology
-
-
Mashup Score: 1New subcutaneous formulation of leuprolide mesylate officially launches in US prostate cancer market - 2 year(s) ago
The ready-to-inject formulation was approved by the FDA in May 2021.
Source: Urology TimesCategories: Latest Headlines, UrologyTweet-
Subcutaneous formulation of leuprolide mesylate now available in US prostate cancer market https://t.co/sTbktCejp5 #urology #urologist #prostatecancer #urooncology
-
-
Mashup Score: 0Destigmatizing Urology: Dr. Pettaway discusses penile cancer - 2 year(s) ago
“When you compound the patient delay and…the physician delay, then you really get a delay in diagnosis,” says Curtis A. Pettaway, MD.
Source: Urology TimesCategories: Latest Headlines, UrologyTweet-
Destigmatizing Urology: Dr. Pettaway discusses penile cancer https://t.co/3ikxbmCA60 #urology #urologist #penilecancer #urooncology #oncology
-
Enfortumab Vedotin approved in EU for urothelial cancer https://t.co/7g1c3nBKJs #urology #urologist #urothelialcancer #bladdercancer #guoncology #urooncology